Rankings
▼
Calendar
TECX FY 2025 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena
TECX
Tectonic Therapeutic, Inc.
$635M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$84M
Net Income
-$74M
EPS (Diluted)
$-4.05
Cash Flow
Operating Cash Flow
-$60M
Free Cash Flow
-$60M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$261M
Total Liabilities
$10M
Stockholders' Equity
$251M
Cash & Equivalents
$254M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$84M
-$58M
-44.9%
Net Income
-$74M
-$58M
-27.9%
← Q4 2024
All Quarters
Q1 2025 →